Continued Presence of Intrastriatal but not Intraventricular Polymer-Encapsulated PC12 Cells is Required for Alleviation of Behavioral Deficits in Parkinsonian Rodents
To date, few studies have systematically evaluated the most appropriate location for grafting catechoiaminergic cells as a potential treatment for Parkinson's disease (PD). The following study was conducted to determine 1) if placement of catecholamine-secreting encapsulated PC12 cells into the...
Main Authors: | Dwaine F. Emerich, Shelley R. Winn, Mark D. Lindner |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
1996-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/096368979600500508 |
Similar Items
-
Therapeutic Potential of a Polymer-Encapsulated L-Dopa and Dopamine-Producing Cell Line in Rodent and Primate Models of Parkinson's Disease
by: Mark D. Lindner Ph.D., et al.
Published: (1998-03-01) -
Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
by: Gilles N. Stormezand, et al.
Published: (2020-01-01) -
Article Commentary: Encapsulated CNTF-Producing Cells for Huntington's Disease
by: Dwaine F. Emerich
Published: (1999-11-01) -
Polymer-Encapsulated Schwannoma Cells Expressing Human Nerve Growth Factor Promote the Survival of Cholinergic Neurons after a Fimbria-Fornix Transection
by: Malcolm Schinstine, et al.
Published: (1995-01-01) -
Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat
by: Kunlin Jin, et al.
Published: (2005-03-01)